How to interpret the results of a 3-hour Oral Glucose Tolerance Test (OGTT) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To interpret the results of a 3-hour Oral Glucose Tolerance Test (OGTT) in pregnancy, focus on the blood glucose values at each time point, with diagnosis of gestational diabetes made when at least two of the following plasma glucose levels are met or exceeded: fasting ≥95 mg/dL, 1 h ≥180 mg/dL, 2 h ≥155 mg/dL, and 3 h ≥140 mg/dL, as per the Carpenter-Coustan criteria 1.

Key Considerations for Interpreting OGTT Results

  • The OGTT should be performed in the morning after an overnight fast of at least 8 hours 1.
  • The test involves drinking a 100-gram glucose solution, with blood drawn before drinking and at hourly intervals for three hours 1.
  • The diagnosis of gestational diabetes is made based on the plasma glucose values measured during the OGTT, using the Carpenter-Coustan criteria 1.

Importance of Proper Diagnosis and Treatment

  • Proper diagnosis and treatment of gestational diabetes are crucial to prevent complications for both mother and baby, including excessive birth weight, preterm birth, and increased risk of type 2 diabetes later in life 1.
  • Treatment may include diet modifications, exercise, blood glucose monitoring, and possibly insulin or oral medications 1.

Timing of the OGTT

  • The OGTT is typically performed between 24-28 weeks of pregnancy for women with risk factors or abnormal glucose screening results 1.
  • The American Diabetes Association (ADA) recommends using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria to optimize gestational outcomes 1.

From the Research

Interpreting 3-Hour Oral Glucose Tolerance Test (OGTT) Results in Pregnancy

The 3-hour OGTT is a diagnostic tool used to assess gestational diabetes mellitus (GDM) in pregnant women. The test measures blood glucose levels at four different time points: fasting, 1 hour, 2 hours, and 3 hours after consuming a 100g glucose solution.

Understanding Abnormal Values

  • A single abnormal value on the 3-hour OGTT is associated with adverse maternal and neonatal outcomes, including macrosomia, large for gestational age, increased mean birthweight, neonatal hypoglycemia, and total cesarean delivery 2.
  • The risk of adverse outcomes is similar to that of women with GDM, with the exception of birthweight 2.
  • Isolated abnormal values at different time points (0,1,2, and 3 hours) are associated with varying risks of macrosomia and large for gestational age 3.

Diagnostic Criteria

  • The American College of Obstetricians and Gynecologists (ACOG) recommends a 2-step approach for diagnosing GDM, with a 3-hour, 100-g OGTT reserved for women with an abnormal 1-hour, 50-g glucose challenge test.
  • The diagnosis of GDM is based on the presence of two or more abnormal values on the OGTT 2, 4.

Clinical Implications

  • Women with one elevated glucose tolerance test value are at increased risk for adverse perinatal outcomes, including cesarean delivery, preeclampsia, chorioamnionitis, and neonatal admission to the intensive care nursery 4.
  • The omission of the third hour glucose measurement from the OGTT may result in a lower diagnosis rate of GDM, but may not substantially alter perinatal outcomes 5.

Preparatory Diet

  • A high carbohydrate preparatory diet does not significantly affect the results of the 3-hour OGTT in pregnancy 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Isolated abnormal value during the 3-hour glucose tolerance test: which value is associated with macrosomia?

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2011

Related Questions

How to interpret a 3-hour glucose tolerance test result in pregnancy, measured in milligrams per deciliter (mg/dL)?
What intervention is indicated for a 28-year-old gravida 1 para 0 (first pregnancy, no previous births) woman at 16 weeks gestation with a history of cervical intraepithelial neoplasia 3 (CIN 3) and a family history of gestational diabetes mellitus (GDM), presenting with normal vital signs, including normothermia (normal temperature), normotension (normal blood pressure), and a normal fetal heart rate?
Can I do a 1-hour glucose tolerance test (GTT) at 30 weeks of pregnancy?
What are the guidelines for interpreting the 3-hour glucose test for Gestational Diabetes Mellitus (GDM)?
What is the typical interval between measurements for a Glucose Tolerance Test (GTT)?
What are the diagnostic criteria for autoimmune thyroiditis (Hashimoto's thyroiditis)?
What are psychiatric pain relievers?
What is the comparative efficacy of Imipenem (Imipenem) with EDTA (Ethylene Diamine Tetraacetic Acid) versus Ceftazidime (Ceftazidime) with Avibactam (Avibactam) for treating Multidrug-Resistant (MDR) Acinetobacter infections?
What is the comparison between Tigecycline and Colistin (Polymyxin E) for the treatment of multidrug-resistant (MDR) Acinetobacter infections?
What is the comparison between Tigecycline and Colistin (Polymyxin E) for the treatment of multidrug-resistant (MDR) Acinetobacter baumannii pneumonia?
Is T4 (tumor size 4) lung cancer with multiple nodules in ipsilateral lobes radically treatable?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.